Over the last 8 months, the Choice Genetics management team has been working intensively on a strategic plan for the coming 5 years, “Stage 2022”. The plan was presented to the Choice Genetics board who gave the green light for its implementation. During the coming months, the conclusions of Stage 2022 will be presented to the global Choice Genetics teams and will be officially launched in the fall of this year.
This strategic plan is built on Choice Genetics’ strong foundations:
- A dedicated and highly skilled team of professionals
- A differentiated product portfolio combining efficiency and sustainability
- A global footprint: Europe, North America, Latin America and Asia
- A powerful R&D engine assuring faster genetic progress in the multi-specie context of Groupe Grimaud
While building our strategic plan, we have always kept our customers at the center of our attention. We are looking forward to discuss together what Stage 2022 will mean for you.